Back to top

Image: Bigstock

Jounce Therapeutics (JNCE) Jumps: Stock Moves 7.4% Higher

Read MoreHide Full Article

Jounce Therapeutics, Inc. was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range $11.17 to $13.57 in the past one-month time frame.

Over the last 30 days, the company witnessed two positive and one negative estimate revision. The Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Jounce Therapeutics currently carries a Zacks Rank #3 (Hold).

A better-ranked stock in the Medical - Drugs space is Jazz Pharmaceuticals Public Limited Company (JAZZ - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is JNCE going up? Or down? Predict to see what others think: Up or Down

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Jazz Pharmaceuticals PLC (JAZZ) - free report >>

Published in